Loading...
Acrux Limited
ACR.AX•ASX
Healthcare
Biotechnology
A$0.02
A$0.001(6.25%)
Acrux Limited (ACR.AX) Financial Performance & Income Statement Overview
Review Acrux Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-39.60%
↓ 39.60%
Operating Income Growth
-190.09%
↓ 190.09%
Net Income Growth
-659.16%
↓ 659.16%
Operating Cash Flow Growth
-712.09%
↓ 712.09%
Operating Margin
-1332.04%
↓ 1332.04%
Gross Margin
-226.68%
↓ 226.68%
Net Profit Margin
-746.38%
↓ 746.38%
ROE
-179.09%
↓ 179.09%
ROIC
-203.45%
↓ 203.45%
Acrux Limited (ACR.AX) Income Statement & Financial Overview
Review Acrux Limited's (ACR.AX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $682000.00 | $4.41M | $7.008M | $1.42M |
| Cost of Revenue | $1.30M | $6.68M | $2.85M | $3.45M |
| Gross Profit | -$618000.00 | -$2.28M | $4.16M | -$2.02M |
| Gross Profit Ratio | -$0.91 | -$0.52 | $0.59 | -$1.43 |
| R&D Expenses | $1.27M | $1.15M | $1.89M | $1.93M |
| SG&A Expenses | $3.16M | $806000.00 | $748000.00 | $960000.00 |
| Operating Expenses | $4.43M | $1.95M | $2.63M | $2.89M |
| Total Costs & Expenses | $5.73M | $8.64M | $5.49M | $6.33M |
| Interest Income | $51000.00 | $83000.00 | $94000.00 | $28000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $252000.00 | $258000.00 | $294000.00 | $301000.00 |
| EBITDA | -$4.04M | -$3.97M | $1.48M | -$4.61M |
| EBITDA Ratio | -$5.93 | -$0.90 | $0.26 | -$3.24 |
| Operating Income | -$5.05M | -$4.23M | $1.52M | -$4.91M |
| Operating Income Ratio | -$7.40 | -$0.96 | $0.22 | -$3.46 |
| Other Income/Expenses (Net) | $2.34M | $83000.00 | -$227000.00 | $28000.00 |
| Income Before Tax | -$2.71M | -$4.15M | $1.29M | -$4.88M |
| Income Before Tax Ratio | -$3.97 | -$0.94 | $0.18 | -$3.44 |
| Income Tax Expense | -$1.73M | -$907000.00 | -$1.24M | -$1.59M |
| Net Income | -$2.56M | -$3.24M | $2.53M | -$3.29M |
| Net Income Ratio | -$3.76 | -$0.73 | $0.36 | -$2.32 |
| EPS | -$0.009 | -$0.01 | $0.009 | -$0.01 |
| Diluted EPS | -$0.009 | -$0.01 | $0.009 | -$0.01 |
| Weighted Avg Shares Outstanding | $289.88M | $289.20M | $286.43M | $286.43M |
| Weighted Avg Shares Outstanding (Diluted) | $289.88M | $289.20M | $286.43M | $286.43M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan